Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Ascierto PA, Fox BA, Urba WJ, Anderson AC, Atkins MB, Borden EC, Brahmer JR, Butterfield LH, Cesano A, Chen DC, de Gruijl TD, Dillman RO, Drake CG, Emens LA, Gajewski TF, Gulley JL, Stephen Hodi FJ, Hwu P, Kaufman D, Kaufman HL, Lotze MT, McNeel DG, Margolin KM, Marincola FM, Mastrangelo MJ, Maus MV, Parkinson DR, Romero PJ, Sondel PM, Spranger S, Sznol M, Weiner GJ, Wigginton JM, Weber JS. Ascierto PA, et al. Among authors: urba wj. J Immunother Cancer. 2020 Apr;8(1):e000878. doi: 10.1136/jitc-2020-000878. J Immunother Cancer. 2020. PMID: 32300051 Free PMC article. No abstract available.
Adoptive cellular therapy.
Sznol M, Urba WJ. Sznol M, et al. Among authors: urba wj. Cancer Chemother Biol Response Modif. 1992;13:191-204. Cancer Chemother Biol Response Modif. 1992. PMID: 1389910 Review. No abstract available.
Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
Sznol M, Clark JW, Smith JW 2nd, Steis RG, Urba WJ, Rubinstein LV, VanderMolen LA, Janik J, Sharfman WH, Fenton RG, et al. Sznol M, et al. Among authors: urba wj. J Natl Cancer Inst. 1992 Jun 17;84(12):929-37. doi: 10.1093/jnci/84.12.929. J Natl Cancer Inst. 1992. PMID: 1629914
Adoptive cellular therapy.
Sznol M, Urba WJ. Sznol M, et al. Among authors: urba wj. Cancer Chemother Biol Response Modif. 1991;12:213-30. Cancer Chemother Biol Response Modif. 1991. PMID: 1931444 Review. No abstract available.
Adoptive immunotherapy.
Sznol M, Urba WJ. Sznol M, et al. Among authors: urba wj. Cancer Chemother Biol Response Modif. 1994;15:213-25. Cancer Chemother Biol Response Modif. 1994. PMID: 7779587 Review. No abstract available.
Adoptive immunotherapy.
Sznol M, Urba WJ. Sznol M, et al. Among authors: urba wj. Cancer Chemother Biol Response Modif. 1993;14:227-48. Cancer Chemother Biol Response Modif. 1993. PMID: 8312104 Review. No abstract available.
243 results